Pfizer Cov X Research LLC - 92121 San Diego, CA

Business Name: Pfizer Cov X Research LLC
Categorized In: Commercial Biotechnical Research
Address: 9381 Judicial Drive # 200, San Diego, CA 92121
Phone Number: (858) 270-5677
Contact Person: Curt Bradshaw, Vice President
Website Address: pfizer.com
NAICS Code: 4242101
SIC Code: 8731
Business Type: B2B (Business to Business)
Founding Year: 2002
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): Unknown
Share This Business:
Similar Businesses: Genestitute - San Diego, CA 92121
Abwiz Bio Inc - San Diego, CA 92121
Abide Therapeutics - San Diego, CA 92121
Miltenyi Biotec Inc - San Diego, CA 92121
Ignyta - San Diego, CA 92121
Center For Aquaculture Tech - San Diego, CA 92121
Aires Pharmaceuticals Inc - San Diego, CA 92121
Oranox - San Diego, CA 92121
Rd Biosciences Inc - San Diego, CA 92121
Zenobia Therapeutics - San Diego, CA 92121
Advantar Laboratories Inc - San Diego, CA 92121
Bps Bioscience - San Diego, CA 92121
Proacta Inc - San Diego, CA 92121
Anaptysbio Inc - San Diego, CA 92121
Nod Pharmaceuticals Inc - San Diego, CA 92121
Kinome Scan - San Diego, CA 92121
Dermatrends Inc - San Diego, CA 92121
One World Lab Inc - San Diego, CA 92121
Motivatrx LLC - San Diego, CA 92121
Mapp Biopharmaceutical Inc - San Diego, CA 92121

Pfizer Cov X Research LLC provides professional Commercial Biotechnical Research from its single location at the coordinates 32.878653,-117.2053.

The company offers B2B variables under the SIC code 8731 and NAICS code 4242101, while making an annual revenue of Unknown and hiring a total of 1 to 4 employees.

Founded in 2002, the company can now be visited at 9381 Judicial Drive # 200, San Diego, California 92121 or contacted through representative Curt Bradshaw, Vice President at (858) 270-5677.

For frequently asked questions and further inquiries about professional Commercial Biotechnical Research, get to know more about Pfizer Cov X Research LLC through its company website at pfizer.com. Engage with this business on its social media platforms through on Twitter and on Facebook.